Published on 29 Nov 2021 on Investing.com
Adagio Therapeutics Upgraded at Morgan Stanley on Omicron Potential By Investing.com
The analyst believes leading antibodies from Eli Lilly and Company (NYSE:LLY) and Regeneron...
Want to become a better investor?
Start tracking your investments with Statfolio
Sign up for free